NM_002732.4(PRKACG):c.240G>A (p.Val80=) AND PRKACG-related disorder

Germline classification:: Likely benign (1 submission)
Last evaluated:: Mar 16, 2023
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV003969799.2

Allele description [Variation Report for NM_002732.4(PRKACG):c.240G>A (p.Val80=)]

NM_002732.4(PRKACG):c.240G>A (p.Val80=)

Gene:

PRKACG:protein kinase cAMP-activated catalytic subunit gamma [Gene - OMIM - HGNC]

Variant type:

single nucleotide variant

Cytogenetic location:

9q21.11

Genomic location:

Preferred name:

NM_002732.4(PRKACG):c.240G>A (p.Val80=)

HGVS:

NC_000009.12:g.69013853C>T
NG_042177.1:g.5271G>A
NM_002732.4:c.240G>AMANE SELECT
NP_002723.2:p.Val80=
LRG_1004t1:c.240G>A
LRG_1004:g.5271G>A
LRG_1004p1:p.Val80=
NC_000009.11:g.71628769C>T
NM_002732.3:c.240G>A

Molecular consequence:

NM_002732.4:c.240G>A - synonymous variant - [Sequence Ontology: SO:0001819]

Condition(s)

Name:: PRKACG-related disorder
Synonyms:: PRKACG-related condition
Identifiers:

Recent activity

Clear Turn Off Turn On

PREDICTED: Homo sapiens endosomal transmembrane epsin interactor 3 (ENTREP3), tr...
PREDICTED: Homo sapiens endosomal transmembrane epsin interactor 3 (ENTREP3), transcript variant X1, mRNA
gi|2462502316|ref|XM_054333907.1|

Nucleotide
PsbM, partial (chloroplast) [Dombeya acutangula]
PsbM, partial (chloroplast) [Dombeya acutangula]
gi|384039333|gb|AFH58061.1|

Protein

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV004783436	PreventionGenetics, part of Exact Sciences	no assertion criteria provided	Likely benign (Mar 16, 2023)	germline	clinical testing

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV004783436

PreventionGenetics, part of Exact Sciences

no assertion criteria provided

Likely benign
(Mar 16, 2023)

germline

clinical testing

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	unknown	not provided	not provided	not provided	not provided	not provided	clinical testing

Details of each submission

From PreventionGenetics, part of Exact Sciences, SCV004783436.2

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	not provided

Description

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	unknown	not provided	not provided	not provided		not provided	not provided	not provided	not provided

Last Updated: Oct 13, 2024

ClinVar

Relating variation to medicine